πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,328 results for β€œChina” Clear

  1. Combined use of TPO-RAs with low-dose anti-CD20 antibody

    China SXT Pharmaceuticals

    Immune Thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

  2. Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid

    China SXT Pharmaceuticals

    Acute Promyelocytic Leukaemia

    phase 3 small molecule active

    1 trial

  3. Coronary Artery Bypass Graft with the use of CPB

    China SXT Pharmaceuticals

    the Efficacy and Safety of Off-pump CABG

    phase 3 other completed

    1 trial

  4. Coronary CTA

    China SXT Pharmaceuticals

    Coronary Artery Disease

    phase 3 other completed

    1 trial

  5. Cytarabine

    China SXT Pharmaceuticals

    AML

    phase 3 small molecule active

    3 trials

  6. Dapagliflozin+Standard Treatment for 12 weeks,washout period for 4 weeks，then Standard Treatment alone for12 weeks

    China SXT Pharmaceuticals

    Pediatric Hereditary Kidney Diseases

    phase 3 small molecule active

    1 trial

  7. Daunorubicin/Idarubicin

    China SXT Pharmaceuticals

    AML, Adult

    phase 3 small molecule active

    1 trial

  8. Decitabine

    China SXT Pharmaceuticals

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  9. Dexamethasone

    China SXT Pharmaceuticals

    Acute Respiratory Distress Syndrome (ARDS)

    phase 3 small molecule active

    1 trial

  10. Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

    China SXT Pharmaceuticals

    Whooping Cough

    phase 3 mab active

    1 trial

  11. Docetaxel+lobaplatin

    China SXT Pharmaceuticals

    Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma

    phase 3 small molecule active

    1 trial

  12. Docetaxel, cisplatin and fluorouracil

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  13. EADM

    China SXT Pharmaceuticals

    Carcinoma, Hepatocellular

    phase 3 small molecule active

    1 trial

  14. Elective nodal irradiation (ENI)

    China SXT Pharmaceuticals

    Esophageal Squamous Cell Carcinoma

    phase 3 other active

    1 trial

  15. Enzalutamide

    China SXT Pharmaceuticals

    Metastatic Hormone Sensitive Prostate Cancer

    phase 3 small molecule active

    1 trial

  16. Epirubicin

    China SXT Pharmaceuticals

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  17. Escitalopram

    China SXT Pharmaceuticals

    Mild-to-moderate Depression

    phase 3 small molecule completed

    1 trial

  18. Everolimus

    China SXT Pharmaceuticals

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  19. Fluticasone/ Formoterol

    China SXT Pharmaceuticals

    Asthma

    phase 3 small molecule active

    1 trial

  20. Fluzoparib

    China SXT Pharmaceuticals

    Breast Cancer Metastatic

    phase 3 small molecule active

    2 trials

  21. Gefitinib

    China SXT Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  22. Gemcitabine,Cisplatin

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  23. Genotype-guided dosingTaiwan algorithm for warfarin

    China SXT Pharmaceuticals

    Stroke

    phase 3 gene therapy completed

    1 trial

  24. Granulocyte Colony-Stimulating Factor(G-CSF)

    China SXT Pharmaceuticals

    Myelodysplastic Syndrome

    phase 3 small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources